Acceleron Pharma Inc

NASDAQ:XLRN   3:59:54 PM EDT
120.55
+4.05 (+3.48%)
Products

FDA Says It Issued A Notice Of Noncompliance To Acceleron Pharma

Published: 04/28/2021 17:05 GMT
Acceleron Pharma Inc (XLRN) - FDA Takes Action for Failure to Submit Required Clinical Trial Results Information to Clinicaltrials.
Gov.
FDA - Issued Its First Notice of Noncompliance to Acceleron Pharma for Failing to Submit Required Summary Results Information to Clinicaltrials.
Gov.
FDA - Notice Gives Acceleron 30 Days to Submit Required Summary Results Information From Trial of Dalantercept in Combination With Axitinib.